One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v128.22.625.625
Copy DOI Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 15 |
Affiliation: South Australian Health and Medical Research Institute, South Australia Pathology, University of Adelaide, Kobe University Hospital, Cardiff University, Novartis (United States), Goethe University Frankfurt, Michigan Center for Translational Pathology, University of Michigan–Ann Arbor, Seoul St. Mary's Hospital, Catholic University of Korea, Jena University Hospital, Amsterdam UMC Location VUmc, Sapienza University of Rome, Oregon Health & Science University, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Singapore General Hospital, The University of Texas MD Anderson Cancer Center, Institut Bergonié, University of Bordeaux, Inserm, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Hospital Universitario de La PrincesaExpanded Phase 1 Study of ABL001, a Potent, Allosteric Inhibitor of BCR-ABL, Reveals Significant and Durable Responses in Patients with CML-Chronic Phase with Failure of Prior TKI Therapy
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
